Skip to main content

D. E. Shaw & Co., Inc.

Position in LKFT — Lakefront Biotherapeutics NV

CIK 1009207 New York, NY

Position in LKFT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,931,363
-$540,177 QoQ
Shares Held
197,844
-8.3% QoQ
Ownership
0.302%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 78 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LKFT Over Time

Shares Held

Position Value (USD)

Derivatives in LKFT

reported options exposure · as of Dec 31, 2021
CallValue
$507,196
CallShares
9,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,016,183,849 across 217 Biotechnology names. LKFT ranks #93 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LKFT

Export CSV
31 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,931,363 197,844
2026-03-31 $6,471,540 215,718
2025-12-31 $8,992,467 274,999
2025-09-30 $6,968,494 201,169
2025-06-30 $4,287,648 153,185
2025-03-31 $1,583,062 63,020
2024-06-30 $415,808 16,780
2024-03-31 $1,663,870 51,673
2023-12-31 $3,074,766 75,640
2023-09-30 $1,981,269 57,345
2023-06-30 $672,801 16,547
2022-12-31 $2,662,622 59,996
2022-09-30 $5,378,353 126,134
2022-06-30 $6,736,343 120,723
2022-03-31 $2,680,194 43,215
2021-12-31 $7,571,554 137,340
2021-12-31 $507,196 9,200
2021-09-30 $7,197,100 136,801
2021-09-30 $484,012 9,200
2021-09-30 $526,100 10,000
2021-06-30 $4,621,898 67,091
2021-06-30 $633,788 9,200
2021-06-30 $688,900 10,000
2021-03-31 $337,037 4,372
2021-03-31 $770,900 10,000
2020-09-30 $1,326,574 9,348
2020-09-30 $1,419,100 10,000
2020-06-30 $1,027,289 5,207
2020-06-30 $1,972,900 10,000
2020-03-31 $1,189,822 6,073
2020-03-31 $1,959,200 10,000